To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.

View sample alert

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Written Question
Cardiovascular Diseases
Tuesday 27th February 2024

Asked by: Jim Shannon (Democratic Unionist Party - Strangford)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what data her Department holds on the number of cases of (a) vascular and (b) venous disease.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

Cardiovascular disease affects approximately seven million people in the United Kingdom, and is a significant cause of disability and death. Further information is available at the following link:

https://www.england.nhs.uk/ourwork/clinical-policy/cvd/

Deposited Papers

Jun. 17 2009

Source Page: Putting feet first: commissioning specialist services for the management and prevention of diabetic foot disease in hospitals. Incl. appendices. 9 p.
Document: DEP2009-1733.pdf (PDF)

Found: Putting feet first: commissioning specialist services for the management and prevention of diabetic foot

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 17 October 2022
Document: Freedom of Information request (FOI 22/1012) - attachment (PDF)

Found: More recently, vascular disease, age 2: 65 years and female sex have been included in the modified CHA2DS2

Deposited Papers

Mar. 20 2009

Source Page: Implementing the national stroke strategy: an imaging guide. 36 p.
Document: DEP2009-0911.pdf (PDF)

Found: Professor Roger Boyle, CBD National Director for Heart Disease and Stroke Dr Erika Denton National

Deposited Papers

Jul. 22 2008

Source Page: Ovarian hyperstimulation syndrome: a short report for the HFEA. By Adam Balen. 20 p.
Document: DEP2008-2052.pdf (PDF)

Found: and vascular permeability.

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 29 August 2022
Document: FOI 22/875 - attachment 5 (PDF)

Found: lacrimal infections, irritations and inflammations Eyelid oedema 1 0 Ocular bleeding and vascular

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023
Document: FOI 23/857 - attachment 2 (PDF)

Found: findings abnormal Gastrointestinal sounds abnormal 1 0 Colitis (excl infective) Crohn's disease

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023
Document: FOI 23/774 - attachment 1 (PDF)

Found: 2 Raynauds syndrome 2 Peripheral arterial occlusive disease 2 Peripheral venous disease (venous insufficiency

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 17 October 2022
Document: Freedom of Information request (FOI 22/981) - attachment 8 (PDF)

Found: corneal bleeding and vascular disorders Conjunctival haemorrhage 1 0 Eyelid movement disorders

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 28 November 2022
Document: Freedom of Information request (FOI 22/1092) - attachment 2 (PDF)

Found: vitreous haemorrhages and vascular disorders Vitreous haemorrhage 1 0 Colour blindness (incl